Design of a Topically Applied Gel Spray Formulation with Ivermectin Using a Novel Low Molecular Weight Gelling Agent, Palmitoyl-Glycine-Histidine, to Treat Scabies.

Scabies Treatment: A New Approach to Combating an Itchy Desert

Scabies, a skin infestation, can be a real itch in the desert of our lives. Ivermectin, a commonly used medication for scabies, is typically administered orally. However, this route can lead to side effects. This research explores a new approach, investigating the potential of a topically applied gel spray formulation containing ivermectin to treat scabies. The researchers formulated a gel spray using a novel gelling agent, palmitoyl-glycine-histidine (Pal-GH), and evaluated its effectiveness in delivering ivermectin to the skin of hairless rats.

A Oasis of Innovation: Topical Ivermectin Delivery

This study presents a novel approach to scabies treatment, potentially offering an alternative to oral administration with fewer side effects.

A Gentle Breeze Across the Desert: Treating Scabies Effectively

The research suggests that topical delivery of ivermectin using a Pal-GH gel spray formulation may offer a more effective and potentially safer approach to treating scabies.

Dr.Camel's Conclusion

Scabies can feel like an endless itch in the desert. This research explores a new way to combat this pesky condition, potentially offering a more comfortable and effective treatment option. The innovative use of a gel spray formulation may bring a new wave of relief to those struggling with this common condition.